Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001231919-25-000342
Filing Date
2025-10-22
Accepted
2025-10-22 19:48:06
Documents
1
Period of Report
2025-10-20

Document Format Files

Seq Description Document Type Size
1 form4-10222025_111059.html 4  
1 form4-10222025_111059.xml 4 16689
  Complete submission text file 0001231919-25-000342.txt   20449
Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 6177782500
RA Capital Healthcare Fund LP (Reporting) CIK: 0001315082 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 251411156

Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 251411157

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 251411154

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 251411153

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 (617) 778-2500
RA Capital Nexus Fund, L.P. (Reporting) CIK: 0001780117 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 251411155

Mailing Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 811591163 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)